美国FDA 指导原则 根据《药品供应链安全法》行业指南草案加强包装层面的药品分销安全 英文原版.pdfVIP

Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should be submitted within 60 days of publication in the Federal Register of the notice announcing the availability of the draft guidance. Submit electronic comments to . Submit written comments to the Dockets Management Staff (HFA-305)